I P van Cooten1, G J Snoek1, A V Nene1, S de Groot2,3, M W M Post4. 1. Rehabilitation Centre Roessingh, Enschede, The Netherlands. 2. Amsterdam Rehabilitation Research Centre | Reade, Amsterdam, The Netherlands. 3. Centre for Human Movement Sciences, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands. 4. Rudolf Magnus Institute of Neuroscience and Centre of Excellence for Rehabilitation Medicine, University Medical Centre Utrecht and De Hoogstraat, Utrecht, The Netherlands.
Abstract
STUDY DESIGN: Prospective cohort study. OBJECTIVE: To assess functional hindrance due to spasticity during inpatient rehabilitation and 1 year thereafter in individuals with spinal cord injury (SCI) and to determine factors that influence the hindrance. SETTING: Eight specialized rehabilitation centres in the Netherlands. METHODS: A total of 203 patients with recent SCI rated the hindrance they perceived due to spasticity in daily living at the start of active rehabilitation (t1), 3 months later (t2), at discharge (t3) and 1 year after discharge (t4). Hindrance was dichotomized into absent or negligible and present. Multilevel regression analyses were performed to determine the course of functional hindrance due to spasticity and its associations with possible determinants-namely, age, gender, cause, lesion level, motor completeness, spasticity and anti-spasticity medication. RESULTS: The percentage of individuals that indicated functional hindrance due to spasticity ranged from 54 to 62% over time and did not change significantly over time (Δt3t1 odds ratio (OR)=0.85, P=0.44; Δt3t2 OR=1.20, P=0.41; Δt3t4 OR=0.91, P=0.67). The percentage of individuals who experienced a lot of hindrance due to spasticity during specific activities ranged from 4 to 27%. The odds for experiencing functional hindrance due to spasticity were significantly higher for individuals with tetraplegia (OR=2.17, P=0.0001), more severe spasticity (OR=5.51, P<0.0001) and for those using anti-spasticity medication (OR=4.18, P<0.0001). CONCLUSION: Functional hindrance due to spasticity occurred in the majority of persons with SCI and did not change significantly during inpatient rehabilitation and 1 year thereafter. Factors that influence hindrance were determined.
STUDY DESIGN: Prospective cohort study. OBJECTIVE: To assess functional hindrance due to spasticity during inpatient rehabilitation and 1 year thereafter in individuals with spinal cord injury (SCI) and to determine factors that influence the hindrance. SETTING: Eight specialized rehabilitation centres in the Netherlands. METHODS: A total of 203 patients with recent SCI rated the hindrance they perceived due to spasticity in daily living at the start of active rehabilitation (t1), 3 months later (t2), at discharge (t3) and 1 year after discharge (t4). Hindrance was dichotomized into absent or negligible and present. Multilevel regression analyses were performed to determine the course of functional hindrance due to spasticity and its associations with possible determinants-namely, age, gender, cause, lesion level, motor completeness, spasticity and anti-spasticity medication. RESULTS: The percentage of individuals that indicated functional hindrance due to spasticity ranged from 54 to 62% over time and did not change significantly over time (Δt3t1 odds ratio (OR)=0.85, P=0.44; Δt3t2 OR=1.20, P=0.41; Δt3t4 OR=0.91, P=0.67). The percentage of individuals who experienced a lot of hindrance due to spasticity during specific activities ranged from 4 to 27%. The odds for experiencing functional hindrance due to spasticity were significantly higher for individuals with tetraplegia (OR=2.17, P=0.0001), more severe spasticity (OR=5.51, P<0.0001) and for those using anti-spasticity medication (OR=4.18, P<0.0001). CONCLUSION: Functional hindrance due to spasticity occurred in the majority of persons with SCI and did not change significantly during inpatient rehabilitation and 1 year thereafter. Factors that influence hindrance were determined.
Authors: A D Pandyan; M Gregoric; M P Barnes; D Wood; F Van Wijck; J Burridge; H Hermens; G R Johnson Journal: Disabil Rehabil Date: 2005 Jan 7-21 Impact factor: 3.033
Authors: S de Groot; A J Dallmeijer; M W M Post; F W A van Asbeck; A V Nene; E L D Angenot; L H V van der Woude Journal: Spinal Cord Date: 2006-02-07 Impact factor: 2.772
Authors: Jane S Mahoney; Joan C Engebretson; Karon F Cook; Karen A Hart; Susan Robinson-Whelen; Arthur M Sherwood Journal: Arch Phys Med Rehabil Date: 2007-03 Impact factor: 3.966
Authors: Gerlienke E Voerman; Cathelijne V Erren-Wolters; Judith F Fleuren; Hermie J Hermens; Alexander C Geurts Journal: Disabil Rehabil Date: 2010 Impact factor: 3.033
Authors: Jacinthe J E Adriaansen; Marcel W M Post; Sonja de Groot; Floris W A van Asbeck; Janneke M Stolwijk-Swüste; Marga Tepper; Eline Lindeman Journal: J Rehabil Med Date: 2013-11 Impact factor: 2.912
Authors: Eric R Theriault; Vincent Huang; Gale Whiteneck; Marcel P Dijkers; Noam Y Harel Journal: J Spinal Cord Med Date: 2016-11-14 Impact factor: 1.985
Authors: Jacqueline Tibbett; Eva G Widerström-Noga; Christine K Thomas; Edelle C Field-Fote Journal: J Spinal Cord Med Date: 2018-01-15 Impact factor: 1.985